Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
Eliyahu V. Khankin(Apellis Pharmaceuticals (United States)), Ravi Thadhani(Emory Healthcare)
Cited by 52
Related Papers
Circulating Angiogenic Factors and the Risk of Preeclampsia
|New England Journal of Medicine|2004|3.6k
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
|New England Journal of Medicine|2003|924
Vitamin D levels and early mortality among incident hemodialysis patients
|Kidney International|2007|791
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784